Who founded Argonaute?

Argonaute was founded by Anthony Parker, Richard Tompkins.

Who are Argonaute's investors?

Argonaute's investors include Oxford Investment Opportunity Network (OION).

Where is Argonaute headquartered?

Argonaute is headquartered in Cardiff, GB.

Argonaute

Cardiff, GB · 1 known investors

Find your way into Argonaute

70 people in our graph share verified history with the Argonaute team — schools, employers, funds. One of them is your warm intro.

John Hortonunlockedknows Mike Khan · together at King's College London (overlapped)

knows the team · via King's College London

×5knows the team · via UCL

×3knows the team · via University of Warwick

×2knows the team · via University College London Hospitals NHS Foundation Trust

Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.

Biotech Deep Tech Digital Health Healthtech

Founders & leadership

Anthony Parker inCo-founderCo-founder of Argonaute RNA, a UK biotech developing siRNA therapeutics for cardiovascular disease. Parker has three decades of experience in investment banking and fund management, with prior non-executive roles in biotech.

Richard TompkinsinCo-founder

Mike Khan inCEOHe previously served as Chief Medical Officer at Silence Therapeutics and has over 25 years of experience in preclinical, translational, and clinical drug development, including bringing siRNA candidates through IND approval and Phase 2 completion; he also held academic positions at University College London and University of Warwick and led a cardiovascular clinic at University Hospitals of Coventry and Warwickshire NHS Trust.

Investors · 1

Oxford Investment Opportunity Network (OION)Oxford · $190K – $2.5M

Frequently asked questions

What does Argonaute do?: Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.
Who founded Argonaute?: Argonaute was founded by Anthony Parker, Richard Tompkins.
Who are Argonaute's investors?: Argonaute's investors include Oxford Investment Opportunity Network (OION).
Where is Argonaute headquartered?: Argonaute is headquartered in Cardiff, GB.